• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝内胆管癌和肝细胞癌血清肿瘤标志物的比较。

Comparison of serum tumor markers for intrahepatic cholangiocarcinoma and hepatocellular carcinoma.

作者信息

Tao Lian-Yuan, Cai Lei, He Xiao-Dong, Liu Wei, Qu Qiang

机构信息

Department of General Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.

出版信息

Am Surg. 2010 Nov;76(11):1210-3.

PMID:21140686
Abstract

Serum tumor markers such as alpha-fetoprotein (AFP), carcinoembryonic antigen, carbohydrate antigen (CA) 19-9, CA242, and CA50 were analyzed to evaluate their diagnostic values in single and combined tests for distinguishing intrahepatic cholangiocarcinoma (ICC) from hepatocellular carcinoma (HCC). Preoperative serum levels of AFP, carcinoembryonic antigen, CA19-9, CA242, and CA50 were measured in 45 ICC and 76 HCC patients. The serum levels and the positive rate of AFP, CA19-9, and CA242 were significantly different between the ICC patients and HCC patients. Although AFP (-) was the most sensitive assay for distinguishing ICC from HCC (91.1%), its specificity was significantly lower than that of CA242 (+) and CA19-9 (+). The combination of AFP (-) and CA242 (+) afforded a high specificity of 94.3 per cent and showed highest accuracy (78.5%). Evaluation of patients without liver cirrhosis also showed similar results. The diagnostic value of CA242 (+) is better than that of CA19-9 (+) and AFP (-) in distinguishing ICC from HCC. Combined detection of AFP (-) and CA242 (+) can improve the specificity and accuracy of diagnosing ICC.

摘要

分析血清肿瘤标志物,如甲胎蛋白(AFP)、癌胚抗原、糖类抗原(CA)19-9、CA242和CA50,以评估它们在区分肝内胆管癌(ICC)与肝细胞癌(HCC)的单项和联合检测中的诊断价值。对45例ICC患者和76例HCC患者术前测定AFP、癌胚抗原、CA19-9、CA242和CA50的血清水平。ICC患者与HCC患者的AFP、CA19-9和CA242的血清水平及阳性率存在显著差异。虽然AFP(-)是区分ICC与HCC最敏感的检测方法(91.1%),但其特异性显著低于CA242(+)和CA19-9(+)。AFP(-)与CA242(+)联合检测的特异性高达94.3%,准确性最高(78.5%)。对无肝硬化患者的评估也显示出类似结果。在区分ICC与HCC方面,CA242(+)的诊断价值优于CA19-9(+)和AFP(-)。联合检测AFP(-)和CA242(+)可提高ICC诊断的特异性和准确性。

相似文献

1
Comparison of serum tumor markers for intrahepatic cholangiocarcinoma and hepatocellular carcinoma.肝内胆管癌和肝细胞癌血清肿瘤标志物的比较。
Am Surg. 2010 Nov;76(11):1210-3.
2
The clinical value of serum CEA, CA19-9, and CA242 in the diagnosis and prognosis of pancreatic cancer.血清癌胚抗原(CEA)、糖类抗原19-9(CA19-9)和糖类抗原242(CA242)在胰腺癌诊断及预后中的临床价值
Eur J Surg Oncol. 2005 Mar;31(2):164-9. doi: 10.1016/j.ejso.2004.09.007.
3
Diagnostic role of serum glypican-3 in differentiating hepatocellular carcinoma from non-malignant chronic liver disease and other liver cancers.血清高尔基糖蛋白-3在鉴别肝细胞癌与非恶性慢性肝病和其他肝癌中的诊断作用。
J Gastroenterol Hepatol. 2010 Jan;25(1):129-37. doi: 10.1111/j.1440-1746.2009.05988.x. Epub 2009 Sep 27.
4
Clinicopathologic features of patients with intrahepatic cholangiocarcinoma who are seropositive for alpha-fetoprotein-L3 and those with combined hepatocellular and cholangiocarcinoma.甲胎蛋白-L3血清学阳性的肝内胆管癌患者以及肝细胞癌合并胆管癌患者的临床病理特征
J Gastroenterol Hepatol. 2006 May;21(5):869-73. doi: 10.1111/j.1440-1746.2006.04257.x.
5
Comparison of alpha-fetoprotein with some other tumour markers in Malaysians with hepatocellular carcinoma.马来西亚肝细胞癌患者中α-甲胎蛋白与其他一些肿瘤标志物的比较。
Malays J Pathol. 1997 Jun;19(1):53-8.
6
Application of Joint Detection of AFP, CA19-9, CA125 and CEA in Identification and Diagnosis of Cholangiocarcinoma.甲胎蛋白、糖类抗原19-9、糖类抗原125和癌胚抗原联合检测在胆管癌鉴别诊断中的应用
Asian Pac J Cancer Prev. 2015;16(8):3451-5. doi: 10.7314/apjcp.2015.16.8.3451.
7
Accuracy of the preoperative determination of tumor markers in the differentiation of liver mass lesions in surgical patients.手术患者肝占位性病变鉴别中肿瘤标志物术前测定的准确性。
Hepatogastroenterology. 2002 May-Jun;49(45):740-5.
8
Potential diagnostic performance of contrast-enhanced ultrasound and tumor markers in differentiating combined hepatocellular-cholangiocarcinoma from hepatocellular carcinoma and cholangiocarcinoma.超声造影和肿瘤标志物在鉴别肝内胆管癌与肝细胞癌及胆管癌中的潜在诊断效能
J Med Ultrason (2001). 2018 Apr;45(2):231-241. doi: 10.1007/s10396-017-0834-1. Epub 2017 Oct 20.
9
Sequential fluctuation pattern of serum des-gamma-carboxy prothrombin levels detected by high-sensitive electrochemiluminescence system as an early predictive marker for hepatocellular carcinoma in patients with cirrhosis.采用高敏电化学发光系统检测血清去γ-羧基凝血酶原水平的序贯波动模式,作为肝硬化患者肝细胞癌的早期预测标志物。
Int J Mol Med. 2002 Mar;9(3):245-50.
10
Evaluation of the diagnostic value of serum tumor markers, and fecal k-ras and p53 gene mutations for pancreatic cancer.血清肿瘤标志物、粪便k-ras和p53基因突变对胰腺癌的诊断价值评估。
Chin J Dig Dis. 2006;7(3):170-4. doi: 10.1111/j.1443-9573.2006.00263.x.

引用本文的文献

1
Anti-carcinogenic effects and mechanisms of actions of fruit peel hydroethanolic extract and limonene in diethylnitrosmine/2-acetylaminofluorene-induced hepatocellular carcinoma in Wistar rats.果皮水乙醇提取物和柠檬烯对二乙基亚硝胺/2-乙酰氨基芴诱导的Wistar大鼠肝细胞癌的抗癌作用及其作用机制
Am J Cancer Res. 2024 Nov 15;14(11):5193-5215. doi: 10.62347/FOYI6658. eCollection 2024.
2
Establishment and validation of a nomogram containing cytokeratin fragment antigen 21-1 for the differential diagnosis of intrahepatic cholangiocarcinoma and hepatocellular carcinoma.用于肝内胆管癌和肝细胞癌鉴别诊断的包含细胞角蛋白片段抗原21-1的列线图的建立与验证
Front Oncol. 2024 Jun 28;14:1404799. doi: 10.3389/fonc.2024.1404799. eCollection 2024.
3
Cholangiocarcinoma: The Current Status of Surgical Options including Liver Transplantation.胆管癌:包括肝移植在内的手术选择现状
Cancers (Basel). 2024 May 21;16(11):1946. doi: 10.3390/cancers16111946.
4
Clinical practice guidelines for molecular tumor marker, 2nd edition review part 2.临床肿瘤分子标志物检测技术指南 第 2 版 解读 2
Int J Clin Oncol. 2024 May;29(5):512-534. doi: 10.1007/s10147-024-02497-0. Epub 2024 Mar 17.
5
Annals of Surgical Oncology Practice Guidelines Series: Management of Primary Liver and Biliary Tract Cancers.《外科肿瘤学年鉴实践指南系列:原发性肝脏和胆道癌的治疗》
Ann Surg Oncol. 2023 Dec;30(13):7935-7949. doi: 10.1245/s10434-023-14255-z. Epub 2023 Sep 11.
6
Vascular invasion and lymph node metastasis mediate the effect of CA242 on prognosis in hilar cholangiocarcinoma patients after radical resection.血管侵犯和淋巴结转移介导了CA242对肝门部胆管癌患者根治性切除术后预后的影响。
Front Oncol. 2022 Dec 12;12:1071439. doi: 10.3389/fonc.2022.1071439. eCollection 2022.
7
Protective Effects of Naringin-Dextrin Nanoformula against Chemically Induced Hepatocellular Carcinoma in Wistar Rats: Roles of Oxidative Stress, Inflammation, Cell Apoptosis, and Proliferation.柚皮苷 - 糊精纳米制剂对Wistar大鼠化学诱导性肝细胞癌的保护作用:氧化应激、炎症、细胞凋亡和增殖的作用
Pharmaceuticals (Basel). 2022 Dec 14;15(12):1558. doi: 10.3390/ph15121558.
8
HCC biomarkers - state of the old and outlook to future promising biomarkers and their potential in everyday clinical practice.肝癌生物标志物——旧有情况及对未来有前景的生物标志物及其在日常临床实践中的潜力展望。
Front Oncol. 2022 Nov 28;12:1016952. doi: 10.3389/fonc.2022.1016952. eCollection 2022.
9
Locoregional Approaches in Cholangiocarcinoma Treatment.胆管癌治疗中的局部区域治疗方法。
Cancers (Basel). 2022 Nov 28;14(23):5853. doi: 10.3390/cancers14235853.
10
Isatin Counteracts Diethylnitrosamine/2-Acetylaminofluorene-Induced Hepatocarcinogenesis in Male Wistar Rats by Upregulating Anti-Inflammatory, Antioxidant, and Detoxification Pathways.异吲哚酮通过上调抗炎、抗氧化和解毒途径来对抗二乙基亚硝胺/2-乙酰氨基芴诱导的雄性Wistar大鼠肝癌发生。
Antioxidants (Basel). 2022 Apr 1;11(4):699. doi: 10.3390/antiox11040699.